Table 29.3.
PRNP nonsense mutations
| PRNP mutation | Codon 129 polymorphism | # of cases in literature | Clinical phenotypes | Age at onset (range)c (years) | Disease duration (range)c (months or years) | Positive FHxa | CSF marker
sensitivity |
EEG PSWC | MRI c/w JCDb | Neuropathology | Neuropathology pheno-type | References | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-3-3 | Total tau | ||||||||||||
| Q145X | MM | 1 | Cog | 38 | 21 years | 0% (0/1) | N/A | N/A | N/A | N/A | NFT, PrP-angio | Atypic | Ghetti et al. (1996) |
| Q160X | MM (4) MV (3) Unknown (4) | 11 | D Cog, Dep Cog, dysauto, neuropathy | 42.1±8.4 (32–59) | 9.6±4.9 (4–21) years | 100% (11/11) | 0% (0/1) | 0% (0/1) | 0% (0/4) | 0% (0/4) | NFT, PrP-angio, AD pathology | Atypical | Owen et al. (1989); Finckh et al.(2000) ; Jayadev et al. (2011); Fong et al., 2016 |
| Q163X | Cis V (10) | 10 | Dysauto, neuropathy, Cog | 33.0 ±3.4 (30–38) | 26.8 ±8.0 (15–33) years | 100% (10/10) | 100% (1/1) | 100%d (1/1) | 0% (0/3) | 0% (0/2) | NFT, PrP-angio, PrP-Plaqs, Sp, V | Atypical | Mead et al. (2013) |
| Y226X | MV (2) Unknown (1) | 3 | D Park, Cog | 55.3 ±17.0 (39–73) | 3.5 ±2.3 (1.5–6) years | 100% (3/3) | 100% (1/1) | N/A | 100% (1/1) | 0% (0/1) | PrP-angio, PrP-Plaqs | Atypical | Jansen et al. (2010) |
| 2bp Del 178 | Unknown (3) | 3 | Dysauto, cog, neuropathy | 42.0± 14.0 (26–52) | 5.5± 6.4 (1–10) years | 100% (3/3) | 100% (2/2) | 100% (1/1) | N/A | 0% (0/2) | N/A | Atypical | Matsuzono et al. (2013) |
From Kim et al. (2017) with permission from Cold Spring Harbor Laboratory Press.
Positive family history of dementia with similar clinical features (as of the proband) or prion disease.
According to most commonly used European 2009 and UCSF 2011 criteria (Zerr et al., 2009; Vitali et al., 2011).
Data on age at onset and duration of disease are shown as mean ± sd (range), unless otherwise indicated.
Positive if > total tau 1200 pg/mL.
AD, Alzheimer-type dementia; Cog, cognitive; c/w, consistent with; D, dementia; Dep, depression; Dysauto, dysautonomia; EEG, electroencephalogram; FHx, family history; JCD, Jakob–Creutzfeldt disease; MRI, magnetic resonance imaging; N/A, not available; NFT, neurofibrillary tangles; Park, parkinsonism; PrP-angio, PrP amyloid angiopathy; PrP-Plqs, PrP-amyloid plaques; PSWC, periodic sharp-wave complexes; Sp, spongiosis; V, vacuolation.